270 related articles for article (PubMed ID: 17467777)
1. Assessing aspirin-induced attenuation of platelet reactivity by flow cytometry.
Hübl W; Assadian A; Lax J; Meixner U; Fang IF; Hagmüller G; Panzer S; Bayer PM
Thromb Res; 2007; 121(1):135-43. PubMed ID: 17467777
[TBL] [Abstract][Full Text] [Related]
2. Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: flow cytometric measurement of aspirin-induced platelet inhibition.
Assadian A; Lax J; Meixner-Loicht U; Hagmüller GW; Bayer PM; Hübl W
J Vasc Surg; 2007 Jun; 45(6):1142-7; discussion 1147. PubMed ID: 17543677
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
4. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
5. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
Fox SC; May JA; Shah A; Neubert U; Heptinstall S
Platelets; 2009 Jun; 20(4):250-9. PubMed ID: 19440925
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
7. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
8. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
[TBL] [Abstract][Full Text] [Related]
9. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
10. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
[TBL] [Abstract][Full Text] [Related]
11. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
Schrör K
Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
[TBL] [Abstract][Full Text] [Related]
13. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
[TBL] [Abstract][Full Text] [Related]
14. Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients.
Lukasik M; Dworacki G; Michalak S; Kufel-Grabowska J; Golanski J; Watala C; Kozubski W
Thromb Res; 2011 Nov; 128(5):e73-80. PubMed ID: 21788065
[TBL] [Abstract][Full Text] [Related]
15. Flowcytometric evidence of platelet activation in patients on aspirin following myocardial infarction.
Ghosh K; Khare A; Shetty S; Nair S; Kulkarni B; Mohanty D
Natl Med J India; 2006; 19(2):73-4. PubMed ID: 16756193
[TBL] [Abstract][Full Text] [Related]
16. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.
Tantry US; Bliden KP; Gurbel PA
J Am Coll Cardiol; 2005 Nov; 46(9):1705-9. PubMed ID: 16256872
[TBL] [Abstract][Full Text] [Related]
17. The influence of VIP and epoprostenol on platelet CD62P expression and primary haemostasis in vitro.
Zwerina J; Landsteiner H; Leitgeb U; Volf I; Petkov V; Zimpfer M; Blaicher A
Platelets; 2004 Feb; 15(1):55-60. PubMed ID: 14985177
[TBL] [Abstract][Full Text] [Related]
18. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
19. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
